These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2506844)

  • 1. Gerontopsychological studies using NAI ('Nürnberger Alters-Inventar') on patients with organic psychosyndrome (DSM III, Category 1) treated with centrophenoxine in a double blind, comparative, randomized clinical trial.
    Pék G; Fülöp T; Zs-Nagy I
    Arch Gerontol Geriatr; 1989 Jul; 9(1):17-30. PubMed ID: 2506844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of centrophenoxine on body composition and some biochemical parameters of demented elderly people as revealed in a double-blind clinical trial.
    Fülöp T; Wórum I; Csongor J; Leövey A; Szabó T; Pék G; Zs -Nagy I
    Arch Gerontol Geriatr; 1990; 10(3):239-51. PubMed ID: 15374499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blind collaborative study of centrophenoxine versus placebo in patients with neurasthenic syndromes].
    Pieschl D; Angersbach P; Kolbe M; Toman M
    Nervenarzt; 1983 Jan; 54(1):48-53. PubMed ID: 6405290
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Hungarian version of the Nuremberg Geronto-psychological Inventory].
    Pék G; Fülöp T
    Orv Hetil; 1991 Oct; 132(42):2319-22. PubMed ID: 1945368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic brain syndrome treated with oxiracetam. A double-blind randomized controlled trial.
    Hjorther A; Browne E; Jakobsen K; Viskum P; Gyntelberg F
    Acta Neurol Scand; 1987 Apr; 75(4):271-6. PubMed ID: 3296624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, clinical, psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life.
    Saletu B; Linzmayer L; Grünberger J; Pietschmann H
    Neuropsychobiology; 1985; 13(1-2):44-52. PubMed ID: 3897895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential effects of meclofenoxate on memory loss in the elderly.
    Marcer D; Hopkins SM
    Age Ageing; 1977 May; 6(2):123-31. PubMed ID: 329662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric studies on synapses of the cerebellar glomerulus: the effect of centrophenoxine treatment in old rats.
    Giuli C; Bertoni-Freddari C; Pieri C
    Mech Ageing Dev; 1980; 14(1-2):265-71. PubMed ID: 6782379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacopsychological effects of flunarizine in geriatric patients with light brainorganic psychosyndrome. Preliminary communication.
    Heinze B; Karrass W; Peters T
    Eur Neurol; 1986; 25 Suppl 1():115-21. PubMed ID: 3530773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Cerutil (centrophenoxine) in patients with cerebral sclerosis].
    Schilter R
    Z Alternsforsch; 1974; 28(3):231-8. PubMed ID: 4619249
    [No Abstract]   [Full Text] [Related]  

  • 11. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P
    J Clin Epidemiol; 2003 Apr; 56(4):367-76. PubMed ID: 12767414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute diazepam poisoning in experimental animals and the effect of centrophenoxine on it].
    Mirchev N
    Eksp Med Morfol; 1976; 15(3):167-70. PubMed ID: 798672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.
    van Dongen MC; van Rossum E; Kessels AG; Sielhorst HJ; Knipschild PG
    J Am Geriatr Soc; 2000 Oct; 48(10):1183-94. PubMed ID: 11037003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability to deactivate the sympathetic nervous system in patients with brainstem infarction; correction of the disorder by centrophenoxine administration.
    Stoica E; Enulescu O; Nicolae A
    Neurol Psychiatr (Bucur); 1983; 21(4):425-39. PubMed ID: 6419342
    [No Abstract]   [Full Text] [Related]  

  • 15. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
    Herrmann WM; Kern U; Röhmel J
    Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of psychoactive drugs used in patients with subacute and chronic cerebrovascular disorders].
    Wasilewski R; Lebiediewa N; Kozłowa E; Wołkow W
    Neurol Neurochir Pol; 1981; 15(4):447-51. PubMed ID: 6799848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the effect of centrophenoxine on experimental animals poisoned with chlordiazepoxide].
    Mirchev N
    Eksp Med Morfol; 1975; 14(4):225-7. PubMed ID: 770143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are animal experiments and clinical prevention of abnormalities possible?].
    Neumann HJ
    Zentralbl Gynakol; 1986; 108(20):1222-7. PubMed ID: 3101316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for measuring mental performance in the elderly and its use in a pilot clinical trial of meclofenoxate in organic dementia (preliminary communication).
    Gedye JL; Exton-Smith AN; Wedgwood J
    Age Ageing; 1972 May; 1(2):74-80. PubMed ID: 4150311
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of acute inner ear diseases (sudden deafness and vestibular disorder) with meclofenoxate and acetylsalicylic acid].
    Weinaug P
    HNO; 1988 Jun; 36(6):226-9. PubMed ID: 3137190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.